NEW YORK (360Dx) – Numares confirmed on Wednesday that its test for diagnosing kidney rejection has received CE-IVD marking. The firm has launched it in Europe.

Called renalTX-Score, the test is the first to be available worldwide that evaluates a metabolic biomarker network, rather than single biomarkers or tissue biopsy for diagnosing acute rejection following a kidney transplant, Numares said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.